Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Figure S3 from Inhibiting ERK5 Overcomes Breast Cancer Resistance to Anti-HER2 Therapy By Targeting the G1–S Cell-Cycle Transition

Jingwei Zhang,Adam J. Pearson,Nitin Sabherwal,Brian A. Telfer,Nisha Ali, Karmern Kan,Qiuping Xu,Wei Zhang,Fuhui Chen, Shiyang Li,Jinhua Wang,Nathanael S. Gray, Blanca Risa-Ebrí, Katherine G. Finegan,Michael J. Cross,Emanuele Giurisato,Alan J. Whitmarsh,Cathy Tournier

crossref（2023）

Cited 0|Views1
No score
Abstract
Lapatinib treatment inhibits tyrosine phosphorylation of HER1/2/3 in both sensitive and resistant breast cancer cells.
More
Translated text
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined